Colin Broom M.D., Director at Nabriva Therapeutics plc (NBRV), sold 5,339 shares at $0.19 ($1K) on 2022-08-02, disclosed to the SEC on 2022-08-04.
Seasonal sale ($1k) by Director — this insider has traded NBRV in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NBRV | BUY | 2019-09-03 | $21K | — | Filing → |
| NBRV | BUY | 2018-06-25 | $19K | — | Filing → |
| NBRV | BUY | 2018-05-23 | $46K | — | Filing → |